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Background
Essex and Herts Air Ambulance Trust (EHAAT) teams
have carried tranexamic acid (TXA) on all missions
since 2012. The CRASH-2 trial demonstrated a reduc-
tion in all-cause mortality in trauma patients thought to
have significant haemorrhage.
Methods
A retrospective audit was undertaken of all EHAAT mis-
sions during 2013. All cases where the patient was classed
as ‘positive’ by the Regional Major Trauma Network triage
tool (MT+ve) were included. The primary outcome was
the administration of the first bolus dose of 1g TXA (or
paediatric appropriate dose). Compliance was defined as
‘patients thought to have significant haemorrhage received
TXA’. Compliance with the local ambulance service guide-
lines (trauma patients with hypotension or tachycardia)
was also reviewed.
Results
84 patients were identified as MT+ve, and of these 15
received TXA. There were 8 patients documented as
having significant haemorrhage. All of these patients
received TXA. Blunt trauma accounted for all but 2 of
the patients. The mean initial pulse rate of those
patients who received TXA was 107 beats per minute
(95% CI =/- 19.9) and the mean pulse rate of those
patients who did not receive TXA was 87 beats per
minute (95% CI +/- 6.2) (p < 0.01). The mean first
recorded systolic blood pressure was 101 mmHg (95%
CI +/- 15.3) for those patients receiving TXA vs. 128
mmHg (95% CI +/- 6.6) for those who did not
(p 0.01).
Conclusions
We have demonstrated that 100% of patients received
TXA if attended by our service and thought to be signifi-
cantly bleeding following trauma. We have also demon-
strated alignment with the local ambulance service
guidelines pertaining to the use of TXA. Further clarifica-
tion is required around the indications for TXA in all
trauma patients, and EHAAT requires a specific standard
operating procedure to ensure that practice is evidence-
based and effective.
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